ReviewClinical journal of the American Society of Nephrology : CJASN2011

The efficacy and safety of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in chronic kidney disease, dialysis, and transplant patients.

Ali Olyaei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.